Filtros de búsqueda

Lista de obras de G Petrova

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

artículo científico publicado en 2017

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries

artículo científico publicado en 2018

Analysis of Healthcare Expenditures in Bulgaria

artículo científico publicado en 2022

Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece

artículo científico publicado en 2021

Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy

artículo científico publicado en 2017

Availability and reimbursement of biological products for severe asthma in Bulgaria

scientific article published on 18 August 2020

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

artículo científico publicado en 2018

Benefits of investment into modern medicines in Central-Eastern European countries.

artículo científico

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

artículo científico publicado en 2017

Chronic obstructive pulmonary disease exacerbations and progression in relation to ambient air pollutants exposure

artículo científico publicado en 2019

Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria

artículo científico publicado en 2017

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

article

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis

artículo científico publicado en 2018

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

artículo científico publicado en 2020

Comparison of Cardiovascular Medicines Prices in Four European Countries

scientific article published on 21 August 2020

Comparison of health-related quality-of-life measurement instruments in diabetic patients

artículo científico publicado en 2014

Complex regional pain syndrome acceptance and the alternative denominations in the medical literature

artículo científico publicado en 2012

Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia.

artículo científico publicado en 2009

Cost of severe hypoglycaemia in nine European countries

artículo científico publicado en 2016

Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

scientific article published on 01 September 2015

Cost-effectiveness analysis of different types of labor for singleton pregnancy: real life data

artículo científico publicado en 2014

Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan

artículo científico publicado en 2024

Costs and outcomes for individuals with psychosis prior to hospital admission and following discharge in Bulgaria

scientific article published on 30 March 2019

Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries

scientific article published on 01 July 2020

EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.

artículo científico publicado en 2018

EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.

artículo científico

EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review

artículo científico publicado en 2019

Economic consequences of the implementation of national screening program for chronic HCV infection

artículo científico publicado en 2019

Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting

artículo científico publicado en 2014

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children - economic evaluation

artículo científico publicado en 2013

Economic evaluation of different screening alternatives for patients with clinically suspected acute deep vein thrombosis

artículo científico publicado en 2013

Efficacy and Safety of Reimbursed Orphan Medicines in Bulgaria – Systematic Review and Meta-analysis (Part I)

artículo científico publicado en 2017

Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List

artículo científico publicado en 2023

Evaluation of consumer satisfaction using the tetra-class model

artículo científico publicado en 2008

Health technology assessment in the Balkans: opportunities for a balanced drug assessment system

artículo científico publicado en 2014

Historical overview of regulatory framework development on pricing and reimbursement of medicines in Bulgaria

scientific article published on 03 April 2019

Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment

artículo científico publicado en 2014

ISO 9001 certification for hospitals in Bulgaria: does it help service?

artículo científico publicado en 2014

Incretins and SGLT-2i Therapy of Type 2 Diabetes - Real Life Study of Their Therapeutic and Economic Effects

artículo científico publicado en 2019

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria

artículo científico publicado en 2020

New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria

scientific article published on 28 April 2020

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.

artículo científico publicado en 2018

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.

artículo científico publicado en 2017

Pharmacist's Perspectives on Administering a COVID-19 Vaccine in Community Pharmacies in Four Balkan Countries

artículo científico publicado en 2021

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

scientific article published on 01 December 2019

Pharmacy network and access to medicines in selected eastern European countries: comparative analysis

artículo científico publicado en 2012

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria

artículo científico publicado en 2019

Policies for biosimilar uptake in Europe: An overview.

artículo científico publicado en 2017

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

artículo científico publicado en 2017

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

artículo científico publicado en 2019

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines

scientific article published on 18 July 2018

Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

artículo científico publicado en 2024

Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study

artículo científico publicado en 2022

Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries

artículo científico publicado en 2018

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs

artículo científico publicado en 2018

Review of Medicine Utilization for Parkinson's Disease Management: The Bulgarian Perspective

artículo científico publicado en 2021

Safety assessment of newly marketed herbal medicines--methodological approach (Ginkgo biloba example in Bulgaria).

artículo científico publicado en 2007

Screening and diagnosis of chronic HCV infection in Bulgaria: A review of the current practice

artículo científico publicado en 2018

Statins utilization and price variations-comparison between Ukraine and Bulgaria

artículo científico publicado en 2018

The European challenges of funding orphan medicinal products

artículo científico publicado en 2018

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

artículo científico publicado en 2017

The applicability of the tetraclass model to the management of the patient satisfaction in the pharmacies

artículo científico publicado en 2009

Triple negative breast cancer in Bulgaria: epidemiological data and treatment patterns based on real world evidence and patient registries

artículo científico publicado en 2021

Use of biologics for psoriasis in Central and Eastern European countries

artículo científico

Use of complementary and alternative medicine by children in Europe: published data and expert perspectives

artículo científico publicado en 2012

Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria

scientific article published on 27 November 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda